Bioventus Inc Class A BVS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
-
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
-
Bioventus Reports Second Quarter Financial Results
-
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
Trading Information
- Previous Close Price
- $11.67
- Day Range
- $11.57–11.92
- 52-Week Range
- $2.85–12.41
- Bid/Ask
- $11.43 / $12.00
- Market Cap
- $765.95 Mil
- Volume/Avg
- 299,479 / 581,686
Key Statistics
- Price/Earnings (Normalized)
- 28.57
- Price/Sales
- 1.39
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,030
- Website
- https://www.bioventus.com
Comparables
Valuation
|
Metric
|
BVS
|
688581
|
603301
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.57 | 19.82 | 24.38 |
Price/Book Value | 5.07 | 2.32 | 1.18 |
Price/Sales | 1.39 | 9.09 | 1.68 |
Price/Cash Flow | 21.47 | 18.61 | 10.16 |
Price/Earnings
BVS
688581
603301
Financial Strength
|
Metric
|
BVS
|
688581
|
603301
|
|---|---|---|---|
Quick Ratio | 0.73 | 22.00 | 1.57 |
Current Ratio | 1.33 | 22.61 | 2.24 |
Interest Coverage | −0.50 | 14,174.28 | 5.28 |
Quick Ratio
BVS
688581
603301
Profitability
|
Metric
|
BVS
|
688581
|
603301
|
|---|---|---|---|
Return on Assets (Normalized) | 3.80% | 11.77% | 1.65% |
Return on Equity (Normalized) | 17.93% | 12.40% | 2.34% |
Return on Invested Capital (Normalized) | 11.03% | 10.48% | 1.91% |
Return on Assets
BVS
688581
603301
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Qtbqdlsn | Yzklbs | $196.0 Bil | |||
| Stryker Corp
SYK
| Znllxrfcc | Zmfpw | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Yxlzzpwy | Vykhz | $124.5 Bil | |||
| Medtronic PLC
MDT
| Bflnjpb | Sjnwc | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Xwxbbpqg | Qckjdw | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Rywm | Brmbn | $30.2 Bil | |||
| DexCom Inc
DXCM
| Mmcghmqmv | Lcpc | $27.3 Bil | |||
| Steris PLC
STE
| Gpvlbjq | Mjxdykh | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Rnhqpgpjqm | Dpm | $21.3 Bil | |||
| Insulet Corp
PODD
| Jmhvfgfsy | Hqtpjm | $16.1 Bil |
United States